Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1977;56:284-288

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cairns, J. A.
Right arrow Articles by Klassen, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cairns, J. A.
Right arrow Articles by Klassen, G. A.

Circulation, Vol 56, 284-288, Copyright © 1977 by American Heart Association


ARTICLES

The effect of propranolol on canine myocardial CPK distribution space and rate of disappearance

JA Cairns and GA Klassen

Canine myocardial CPK was partially purified and injected into 11 conscious mongreal dogs. From serial serum CPK measurements in each dog, mean Kd was calculated as 0.0047 +/- 0.0009 (+/- SD) min-1. Correlation coefficients indicated that CPK disappearance rate was well described by a single exponential expression. Kd measured on consecutive days in four dogs varied minimally. CPK distribution space ranged from 74 to 134% of plasma volume. Propranolol loading with 0.3 mg/kg or 2 mg/kg, followed by hourly maintenance doses, resulted in increased Kd in eight of ten dogs, mean Kd rising from .0048 min-1 to .0059 min-1 (P less than 0.02). Propranolol appeared to increase plasma volume but had no significant effect on the relationship of CPK distribution space to plasma volume. If the serial CPK technique were used to measure infarct size, using an average Kd, propranolol might produce artifactual reduction of infarct size measuremnt by increasing Kd and possibly by increasing plasma volume. The obligation to assess the effect upon CPK Kd and distribution space of an agent designed to limit infarct size is apparent.